The global clinical trials matching software market was valued at USD 210.7 million in 2025 and is expected to reach USD 237.9 million in 2026. The market is projected to expand to USD 595.3 million by 2033, registering a 14.0% CAGR from 2026 to 2033. The market is being driven by the increasing complexity of clinical trials, growing adoption of artificial intelligence (AI) and machine...

Clinical trials are becoming increasingly complex, creating stronger demand for technologies capable of managing patient randomization, treatment allocation, drug supply, and operational coordination. Against this backdrop, the randomization and trial supply management (RTSM) market is gaining momentum as sponsors, contract research organizations (CROs), and other clinical research stakeholders...